Healthcare Industry News: GE Capital
News Release - April 14, 2010
Medtronic Names Caroline Stockdale as Senior Vice President of Human ResourcesMINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ) today announced it has named Caroline Stockdale as senior vice president of human resources effective April 30, 2010. In her role, Ms. Stockdale will report to Medtronic Chairman and CEO, William A. Hawkins.
Ms. Stockdale will be responsible for the company’s worldwide human resources function including: global talent initiatives, leadership development, diversity and inclusion, and compensation and benefits oversight. She will serve on Medtronic’s executive committee. The company’s global workforce exceeds 40,000 employees in 120 countries.
“Caroline’s global strategic business experience and demonstrated ability to lead transformational change make her uniquely qualified to take on this important role at Medtronic,” said Hawkins. “Her experience will be instrumental as we work to further optimize our global workforce and drive growth across the company.”
Ms. Stockdale previously served as a senior human resources executive in the United States and Europe at several major corporations including Warner Music Group, American Express Financial Advisors (now Ameriprise), and GE Capital Corporation. Most recently, she served as vice president of revenue cycle operations for Accretive Health, the largest privately-held revenue cycle service provider for large hospitals.
Ms. Stockdale, received a bachelor’s of arts degree with honors from the University of Sheffield, Sheffield, England, with an emphasis in political theory, French and linguistics. She is a qualified U.K. chartered accountant (ACA), and a Six Sigma Black Belt.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsAustin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies